|
|
||||||||
ORIGINAL RESEARCH COMMUNICATION |
1 From the Division of Preventive Medicine, Department of Medicine, Brigham and Womens Hospital and Harvard Medical School, Boston (HDS, JMG, SL, and JEB); the Departments of Epidemiology (HDS and JEB) and Nutrition (SL), Harvard School of Public Health, Boston; the Massachusetts Veterans Epidemiology Research and Information Center, VA Boston Healthcare System, Boston (HDS and JMG); and the Department of Ambulatory Care and Prevention, Harvard Medical School, Boston (JEB).
Background: Despite emerging evidence of the role of flavonoids in cardiovascular disease (CVD) prevention, the association remains unclear.
Objective: We examined whether flavonoids and selected flavonols and flavones or their food sources are associated with CVD risk.
Design: Women (n = 38 445) free of CVD and cancer participated in a prospective study with a mean follow-up of 6.9 y. On the basis of a food-frequency questionnaire, total flavonoids and selected flavonols and flavones were categorized into quintiles, and food sources were categorized into 4 groups. Relative risks were computed for important vascular events (519 events; excluding revascularizations) and CVD (729 events), including myocardial infarction, stroke, revascularization, and CVD death.
Results: The mean flavonoid intake was 24.6 ± 18.5 mg/d, primarily as quercetin (70.2%). For both CVD and important vascular events, no significant linear trend was observed across quintiles of flavonoid intake (P = 0.63 and 0.80, respectively). No individual flavonol or flavone was associated with CVD. Broccoli and apple consumption were associated with nonsignificant reductions in CVD risk: 2530% and 1322%, respectively. A small proportion of women (n = 1185) consuming ≥4 cups (946 mL) tea/d had a reduction in the risk of important vascular events but with a nonsignificant linear trend (P = 0.07).
Conclusions: Flavonoid intake was not strongly associated with a reduced risk of CVD. The nonsignificant inverse associations for broccoli, apples, and tea with CVD were not mediated by flavonoids and warrant further study.
Key Words: Flavonoids cardiovascular disease diet nutrition women primary prevention
This article has been cited by other articles:
![]() |
M. M. Dohadwala and J. A. Vita Grapes and Cardiovascular Disease J. Nutr., September 1, 2009; 139(9): 1788S - 1793S. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Arab, W. Liu, and D. Elashoff Green and Black Tea Consumption and Risk of Stroke: A Meta-Analysis Stroke, May 1, 2009; 40(5): 1786 - 1792. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Hooper, P. A Kroon, E. B Rimm, J. S Cohn, I. Harvey, K. A Le Cornu, J. J Ryder, W. L Hall, and A. Cassidy Flavonoids, flavonoid-rich foods, and cardiovascular risk: a meta-analysis of randomized controlled trials Am. J. Clinical Nutrition, July 1, 2008; 88(1): 38 - 50. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. D. Sesso, J. M. Gaziano, D. J.A. Jenkins, and J. E. Buring Strawberry Intake, Lipids, C-Reactive Protein, and the Risk of Cardiovascular Disease in Women J. Am. Coll. Nutr., August 1, 2007; 26(4): 303 - 310. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Lin, K. M. Rexrode, F. Hu, C. M. Albert, C. U. Chae, E. B. Rimm, M. J. Stampfer, and J. E. Manson Dietary Intakes of Flavonols and Flavones and Coronary Heart Disease in US Women Am. J. Epidemiol., June 1, 2007; 165(11): 1305 - 1313. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J Mink, C. G Scrafford, L. M Barraj, L. Harnack, C.-P. Hong, J. A Nettleton, and D. R Jacobs Jr Flavonoid intake and cardiovascular disease mortality: a prospective study in postmenopausal women Am. J. Clinical Nutrition, March 1, 2007; 85(3): 895 - 909. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W. Erdman Jr., D. Balentine, L. Arab, G. Beecher, J. T. Dwyer, J. Folts, J. Harnly, P. Hollman, C. L. Keen, G. Mazza, et al. Flavonoids and Heart Health: Proceedings of the ILSI North America Flavonoids Workshop, May 31-June 1, 2005, Washington, DC J. Nutr., March 1, 2007; 137(3): 718S - 737S. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. M Popkin, L. E Armstrong, G. M Bray, B. Caballero, B. Frei, and W. C Willett A new proposed guidance system for beverage consumption in the United States Am. J. Clinical Nutrition, March 1, 2006; 83(3): 529 - 542. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. M. C. Zhang Protective Effect of Quercetin on Aroclor 1254-Induced Oxidative Damage in Cultured Chicken Spermatogonial Cells Toxicol. Sci., December 1, 2005; 88(2): 545 - 550. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Song, J. E. Manson, J. E. Buring, H. D. Sesso, and S. Liu Associations of Dietary Flavonoids with Risk of Type 2 Diabetes, and Markers of Insulin Resistance and Systemic Inflammation in Women: A Prospective Study and Cross-Sectional Analysis J. Am. Coll. Nutr., October 1, 2005; 24(5): 376 - 384. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Stangl, M. Lorenz, A. Ludwig, N. Grimbo, C. Guether, W. Sanad, S. Ziemer, P. Martus, G. Baumann, and K. Stangl The Flavonoid Phloretin Suppresses Stimulated Expression of Endothelial Adhesion Molecules and Reduces Activation of Human Platelets J. Nutr., February 1, 2005; 135(2): 172 - 178. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Halliwell, J. Rafter, and A. Jenner Health promotion by flavonoids, tocopherols, tocotrienols, and other phenols: direct or indirect effects? Antioxidant or not? Am. J. Clinical Nutrition, January 1, 2005; 81(1): 268S - 276S. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A Vita Polyphenols and cardiovascular disease: effects on endothelial and platelet function Am. J. Clinical Nutrition, January 1, 2005; 81(1): 292S - 297S. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. C. Arts and P. C. Hollman Polyphenols and disease risk in epidemiologic studies Am. J. Clinical Nutrition, January 1, 2005; 81(1): 317S - 325S. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Svehlikova, S. Wang, J. Jakubikova, G. Williamson, R. Mithen, and Y. Bao Interactions between sulforaphane and apigenin in the induction of UGT1A1 and GSTA1 in CaCo-2 cells Carcinogenesis, September 1, 2004; 25(9): 1629 - 1637. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L Donovan Flavonoids and the risk of cardiovascular disease in women Am. J. Clinical Nutrition, March 1, 2004; 79(3): 522 - 523. [Full Text] [PDF] |
||||
![]() |
H. D Sesso, J M. Gaziano, S. Liu, and J. E Buring Reply to JL Donovan Am. J. Clinical Nutrition, March 1, 2004; 79(3): 523 - 523. [Full Text] [PDF] |
||||
![]() |
L. Gu, M. A. Kelm, J. F. Hammerstone, G. Beecher, J. Holden, D. Haytowitz, S. Gebhardt, and R. L. Prior Concentrations of Proanthocyanidins in Common Foods and Estimations of Normal Consumption J. Nutr., March 1, 2004; 134(3): 613 - 617. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |